MedPath

Glucose Monitoring in Tissue Transfers

Not Applicable
Withdrawn
Conditions
Reconstructive Tissue Surgery
Interventions
Device: Continuous glucose monitoring system
Registration Number
NCT00962130
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

The purpose of this study is to determine if 1) a continuous glucose monitoring system can measure glucose levels in transferred tissue during reconstructive surgery, and 2) if glucose measurements from a continuous glucose monitoring system correlate with tissue blood perfusion.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • presence of a soft tissue deformity where reconstruction with a pedicled or free tissue transfer is indicated
  • age 18 and over
  • ability to follow-up post-operatively
Exclusion Criteria
  • age less than 18
  • prisoner status
  • inability to participate in a standard post-operative follow-up visit

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Blood Glucose MeasurementContinuous glucose monitoring systemSubjects have sensors placed on skin before surgery and these sensors will measure the subject's glucose until the third day after surgery when they are removed.
Primary Outcome Measures
NameTimeMethod
Perfusion and tissue transfer outcome during reconstructive surgery predicted by continuous glucose monitoring of tissueUp to three days post-op
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Wisconsin

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath